Rochester, NY 9/1/2009 8:41:23 AM
YM BioSciences Inc. YMI, Trading Down 18 Cents at End Session
YM BioSciences Inc. YMI
Shares of YM BioSciences Inc. soared 68% Tuesday on nearly 11 times the normal daily volume. Analysts said they weren't sure what was driving the stock higher, and the company said in a statement that its policy is not to comment on unusual market activity.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to BOTTOM of this page for free stock alerts, or visit our site.
Last Trade: 1.71
Day's Range: 1.65 - 1.97
52wk Range: 0.20 - 2.24
Change: Down 0.18 (9.52%)
Volume: 1,364,081
Avg Vol (3m): 573,600
ABOUT YM BioSciences Inc.
YM Biosciences, Inc., a biopharmaceutical company, develops products primarily for the treatment of patients with cancer worldwide. Its product candidates in the clinical stage of development include Nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor designed to treat epithelial cancers, as well as for nasopharangeal cancer and for head and neck cancer; AeroLEF, a proprietary formulation of free and liposome-encapsulated fentanyl administered by pulmonary inhalation for the treatment of severe and moderate acute pain, including cancer pain; and Tesmilifene, a small molecule drug with multiple modes of action that demonstrated enhancement of the activity of traditional chemotherapy. The company, formerly known as York Medical, Inc., was founded in 1994 and is based in Mississauga, Canada.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
